Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05230524 · ClinicalTrials.gov registry record

DIAMOND AF Post-Approval Study

A clinical trial, sponsored by Medtronic Cardiac Ablation Solutions.

Terminated
Registry status
84
Enrollment target

NCT05230524 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05230524 was terminated before completion, sponsored by Medtronic Cardiac Ablation Solutions.

TERMINATED
Registry status
84 participants
Enrollment target

Study Summary

The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial

Interventions

  • DEVICE DiamondTemp™ Ablation System

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2022-02-28
Est. Completion 2025-12-17

What the Registry Record Tells You About NCT05230524

The ClinicalTrials.gov registry entry for NCT05230524 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which DiamondTemp™ Ablation System is the first listed.

NCT05230524 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05230524 about?

NCT05230524 is a clinical study titled "DIAMOND AF Post-Approval Study". The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial

What is the current status of trial NCT05230524?

This trial is currently terminated. The enrollment target is 84 participants. The study started on 2022-02-28. Estimated completion is 2025-12-17.

What interventions are being tested in trial NCT05230524?

The interventions under investigation include: DiamondTemp™ Ablation System (DEVICE).

Who is sponsoring clinical trial NCT05230524?

This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.